Company

S-CORE™ Platform Technology

The S-CORE™ Platform Technology is a minimally invasive approach to repair joint damage. The S-Core™ Platform Technology utilizes an Implant that is placed minimally invasively into the subchondral bone. This bone is found just below the cartilage and is considered to be the “foundation” of the joint. If you are experiencing pain, it is likely caused by damage to the bone caused by overuse or from injury. The S-Core™ Implant can be used in virtually any joint including the knee, toe, foot, ankle, elbow, and shoulder. Damage to these joints is the basis for degenerative joint disease. The S-Core™ Platform Technology is very versatile and provides the surgeon with proprietary instruments to safely target the damaged bone and can provide a platform for a scaffold repair.

S-CORE™ as an Alternate

S-Core™ Platform Technology provides the surgeon an alternative for the current procedures that uses advanced technology for an improved repair.

S-CORE™ May Be The Best Choice For You

The S-CORE™ Platform Technology is a minimally invasive. Has been shown to facilitate early pain relief and a quicker return to activity. Please contact your surgeon to see if S-Core™ would be a good solution for you.

S-CORE™ Platform Technology

The S-CORE™ Platform Technology is a minimally invasive approach to reconstruct fractures and joint damage. The S-Core™ Implant is designed to be be used in many of the joints in the body including the knee, hand, wrist, ankle, elbow and the shoulder. Damage to these joints is the basis for degenerative joint disease progression.

The S-Core™ Countersink and Coring Reamer provide the surgeon with proprietary instruments to safely target the damaged bone and to successfully reconstruct the bone and the joint after traumatic damage.

Our Services

Management

Thomas Kinder Chief Executive Officer 30+ years experience in medical devices and life sciences. Executive Management

Development

First Case in Human May 2020, Post-Operative clinical data​ collection started, Q3 - Controlled Market Launch (U.S. Only)

Please fill in the fields below and we will contact you.

Please fill in the fields below and we will contact you.